Oncology Supportive Care Deal: Menarini Asia-Pacific partnered with Pharmacosmos to register, commercialize and distribute Cosela® (trilaciclib) across multiple Asia-Pacific markets, aiming to protect bone marrow from chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer. Public Health Alerts: A new U.S. analysis found 76% of accidental/undetermined overdose deaths (2022–2024) happened when the person was alone, underscoring the need to expand opioid antagonist access and bystander response. Drug Pricing Transparency: A bipartisan U.S. Senate bill advanced that would require hospitals to post prices for “shoppable” services in radiology and other areas, with penalties for noncompliance. Food Safety Recall Watch: Taiwan’s health ministry said a suspected benzo[a]pyrene contamination in camellia oil is unrelated to a prior scandal, with recalls underway for affected batches. Pharma Manufacturing Capacity: Hikal commissioned a cGMP-compliant pilot plant in Pune to speed development, scale-up and clinical manufacturing for global partners. Mental Health & AI Scrutiny: OpenAI is facing lawsuits tied to alleged dangerous ChatGPT medical advice, adding pressure for stronger safeguards around health emergencies. Health System Oversight: Bermuda’s pharmacy oversight rules expand under a new act, drawing criticism over rushed consultation and subjective licensing controls. Digital Health in Care Delivery: Salmaniya Medical Complex in Bahrain is rolling out pharmacy automation, including robots to dispense medication and smarter stock monitoring.